Fig. 1: RSV hospitalizations per 100,000 people across age groups before and after the introduction of three RSV prevention strategies. | npj Vaccines

Fig. 1: RSV hospitalizations per 100,000 people across age groups before and after the introduction of three RSV prevention strategies.

From: Predicted effectiveness of vaccines and extended half-life monoclonal antibodies against RSV hospitalizations in children

Fig. 1

Annual RSV hospitalizations per 100,000 people over time and across age groups are presented for A maternal immunization, B extended half-life monoclonal antibodies, and C live-attenuated vaccines. Year 0 corresponds to the RSV hospitalization incidence before the introduction of RSV prevention strategies. The predicted RSV hospitalization incidence over time is plotted for Years 1 to 8 after the introduction of the intervention. We assumed 85–95% coverage for all three interventions. The color of the lines corresponds to each age group as indicated by the legend.

Back to article page